Beyond the Clinic: AI Gait Analysis Signals a New Era of Proactive Health

NEW YORK, NY – August 05, 2026 – For decades, the practice of medicine has been defined by a fundamental disconnect: healthcare happens within the four walls of a clinic, while life happens everywhere else. This has left clinicians with a fragmented, episodic view of patient health, pieced together from infrequent appointments. A new strategic partnership announced today between AI-pioneer OneStep and care delivery specialist 1 True Health aims to permanently bridge that gap, signaling a significant move in the industry’s slow but steady pivot from reactive treatment to proactive, continuous health management.

At its core, the collaboration integrates OneStep’s smartphone-based movement intelligence platform with 1 True Health’s ecosystem of technology and human-led Care Navigators. The goal is to create a constant stream of objective, real-world health data, giving providers the insights needed to intervene earlier, personalize care more effectively, and ultimately improve outcomes for patients, particularly seniors and those with chronic conditions.

The Sixth Vital Sign: Turning Movement into Data

The linchpin of this partnership is OneStep’s novel technology, which effectively transforms any smartphone into a clinical-grade motion analysis lab. The company was founded on a simple but profound premise, as stated by CEO Tomer Shussman: "Everyday movement is one of the most powerful indicators of a person's health." By leveraging the sophisticated sensors already built into our phones, OneStep’s AI-powered platform captures and analyzes over 30 distinct gait parameters—from walking speed and stride length to asymmetry and balance.

This is not just step counting. The system, which requires no extra wearables, captures data at 100 Hz during a short, 30-second walk. Proprietary algorithms then translate this raw data into clinically meaningful insights. The technology is listed with the FDA as a Class I medical device, a designation for low-risk devices exempt from the lengthy 510(k) premarket approval process, allowing for faster market entry while still falling under regulatory oversight.

Crucially, the platform’s clinical validity isn't just a marketing claim. A 2022 peer-reviewed study in the Journal of Orthopaedic Surgery and Research found OneStep’s smartphone-based analysis demonstrated “moderate-to-excellent” reliability when compared to gold-standard motion-capture laboratories. This level of accuracy allows the technology to do more than just monitor; it can predict. One of the platform’s most compelling features is its ability to analyze gait trends and reportedly predict an elevated risk of falling up to two weeks before an event occurs, offering a critical window for intervention.

The Human Element: Marrying AI Insights with Navigated Care

While advanced technology can generate a flood of data, its value is only realized when it leads to meaningful action. This is where 1 True Health enters the equation. The company has built its model around tackling the chronic engagement gap in healthcare, particularly among the elderly. As of 2022, less than 1.5% of eligible U.S. seniors were participating in monthly wellness checkup programs, leaving a massive population underserved between doctor visits.

1 True Health addresses this by combining its own technology platform with a team of experienced Care Navigators who act as a persistent, supportive link between patients and their clinical teams. They manage everything from medication adherence to daily health concerns, effectively extending the reach of the healthcare system into the home.

"Our vision is to help providers deliver the best and most effective healthcare experience possible where a patient spends over 99% of their time – in the home," explained Shawn Smith, Chief Executive Officer of 1 True Health. The partnership with OneStep enriches this model significantly. The objective movement data from OneStep provides the “what”—a subtle decline in gait speed, an increase in stride variability. 1 True Health’s Care Navigators provide the “so what” and “now what”—contacting the patient, assessing the situation, and escalating to a clinician if necessary. It’s a symbiotic relationship where AI provides the signal and the human provides the context and response, creating a closed-loop system for proactive care.

The New Economics of Home Health

This partnership is not occurring in a vacuum. It is a strategic response to powerful market forces, including an aging population, the rising prevalence of chronic diseases, and an industry-wide push toward value-based care. The remote patient monitoring market, valued at over $26 billion in 2025, is projected to explode to over $110 billion by 2033, and this growth is creating a fiercely competitive and rapidly consolidating landscape.

However, the true catalyst for adoption often lies in reimbursement. The Centers for Medicare & Medicaid Services (CMS) has been actively expanding financial incentives for remote care. The key here is Remote Therapeutic Monitoring (RTM), a set of billing codes focused on musculoskeletal and respiratory data. For 2026, CMS introduced new RTM codes (such as 98985 and 98979) that offer unprecedented flexibility, allowing providers to bill for shorter monitoring periods and lower-intensity management. This regulatory shift is a game-changer, significantly lowering the financial barrier for providers to adopt technologies like OneStep and making the business case for proactive monitoring undeniable.

By combining OneStep's RTM-ready technology with 1 True Health's established care management framework, the partnership offers healthcare organizations a turnkey solution that not only promises better patient outcomes but also opens up new, sustainable revenue streams. It’s an astute strategic move that aligns clinical innovation with financial viability, a combination that has historically proven elusive for many digital health ventures. As healthcare organizations look for ways to improve efficiency and manage complex patient populations outside the hospital, this integrated model of AI-driven data, human-led engagement, and clear financial ROI presents a compelling blueprint for the future of care delivery.